Third Party Venue: HealthTech Innovation Consortium (HTI-C)

Lead partner: Hôpital Foch
Consortium members: Hôpital Fondation Adolphe de Rothschild, Medicen Paris Region, Université Versailles Saint Quentin en Yvelines (UVSQ)
Partners: CEA, LNE, Résah, DocCity, Ville de Suresnes, CCI IdF

The HTIC supports the development of digital technologies in healthcare across all the activities of its component hospitals, starting with the "Head and Neck/neurosciences" and "Women's Health" (Femtech) specialties. It provides a comprehensive offering from ideation to commercialization, with the idea of involving end-users (doctors, caregivers, patients).

Foch Hospital

51 663

surgical procedures per year

63 522

emergency room visits

3 503

births per year

62 000

inpatient care

More than 600

beds

Over 264,000

annual consultations (excluding maternity)

Nearly 200

clinical research studies

Rothschild Foundation

15 880

day hospital stays

162

inpatient beds

Over 350,000

consultations and technical procedures per year

Over 45,000

emergency ophthalmology visits per year

More than 180

clinical research studies

The Tiers Lieu service offering

Services offered:

  • Clinical and medico-economic studies;
  • Real-life studies;
  • Assessment of digital technologies with AI (including CE marking);
  • Co-design and user-centered methodology (patients, relatives, healthcare professionals);
  • Regulatory support and accompaniment for market access;
  • Access to high-level testing grounds in various fields of expertise.

Expertise mobilized:

  • Living Lab at Hôpital Foch ;
  • Data science and health data warehouses (Hôpital Foch, HFAR) ;
  • Medicoeconomic evaluation center.

Tiers Lieu projects

Project: COLPOFOCH

Supplier: École Polytechnique

Solution: Mueller polarimetric colposcope with automatic deep learning algorithms to improve detection of precancerous cervical lesions.

Need: To improve the reliability and sensitivity of cervical cancer screening, reduce diagnostic errors, and optimize patient care pathways.

Tiers-Lieu's contribution:
o Clinical and medico-economic evaluation under real-life conditions;
o Access to experimental sites (Hôpital Foch and HFAR);
o Support for regulatory certification and CE marking.